These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34722246)

  • 1. Multiparameter MRI Model With DCE-MRI, DWI, and Synthetic MRI Improves the Diagnostic Performance of BI-RADS 4 Lesions.
    Sun SY; Ding Y; Li Z; Nie L; Liao C; Liu Y; Zhang J; Zhang D
    Front Oncol; 2021; 11():699127. PubMed ID: 34722246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric MRI model with synthetic MRI, DWI multi-quantitative parameters, and differential sub-sampling with cartesian ordering enables BI-RADS 4 lesions diagnosis with high accuracy.
    He H; Song M; Tian Z; Gao N; Ma J; Wang Z
    Front Oncol; 2023; 13():1180131. PubMed ID: 38250550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic MRI, multiplexed sensitivity encoding, and BI-RADS for benign and malignant breast cancer discrimination.
    Liu J; Xu M; Ren J; Li Z; Xi L; Chen B
    Front Oncol; 2022; 12():1080580. PubMed ID: 36818669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The value of synthetic MRI in differential diagnosis of benign and malignant breast lesions].
    Che SN; Li J; Xue M; Song Y; Zhao LY; Guo N; Tian Y; Xie LZ; Zhao XM; Zhou CW
    Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):872-877. PubMed ID: 34407594
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative DWI implemented after DCE-MRI yields increased specificity for BI-RADS 3 and 4 breast lesions.
    Dijkstra H; Dorrius MD; Wielema M; Pijnappel RM; Oudkerk M; Sijens PE
    J Magn Reson Imaging; 2016 Dec; 44(6):1642-1649. PubMed ID: 27273694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of Synthetic Relaxometry and Diffusion Measures in the Differentiation of Benign and Malignant Breast Lesions as Compared to BI-RADS.
    Gao W; Zhang S; Guo J; Wei X; Li X; Diao Y; Huang W; Yao Y; Shang A; Zhang Y; Yang Q; Chen X
    J Magn Reson Imaging; 2021 Apr; 53(4):1118-1127. PubMed ID: 33179809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic magnetic resonance imaging for primary prostate cancer evaluation: Diagnostic potential of a non-contrast-enhanced bi-parametric approach enhanced with relaxometry measurements.
    Arita Y; Akita H; Fujiwara H; Hashimoto M; Shigeta K; Kwee TC; Yoshida S; Kosaka T; Okuda S; Oya M; Jinzaki M
    Eur J Radiol Open; 2022; 9():100403. PubMed ID: 35242886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative apparent diffusion coefficient metrics for MRI-only suspicious breast lesions: any added clinical value?
    Li X; Wang H; Gao J; Jiang L; Chen M
    Quant Imaging Med Surg; 2023 Oct; 13(10):7092-7104. PubMed ID: 37869329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An MRI-Based Radiomics Model for Predicting the Benignity and Malignancy of BI-RADS 4 Breast Lesions.
    Zhang R; Wei W; Li R; Li J; Zhou Z; Ma M; Zhao R; Zhao X
    Front Oncol; 2021; 11():733260. PubMed ID: 35155178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion tensor imaging for characterizing tumor microstructure and improving diagnostic performance on breast MRI: a prospective observational study.
    Luo J; Hippe DS; Rahbar H; Parsian S; Rendi MH; Partridge SC
    Breast Cancer Res; 2019 Sep; 21(1):102. PubMed ID: 31484577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of noncontrast MRI in evaluating breast imaging reporting and data system category 0 lesions on digital mammograms.
    Zhang R; Xu M; Zhou C; Ding X; Lu H; Ge M; Du L; Bu Y
    Quant Imaging Med Surg; 2022 Aug; 12(8):4069-4080. PubMed ID: 35919041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of diffusion-weighted imaging with synthetic b-values in breast tumors: comparison with dynamic contrast-enhanced and multiparametric MRI.
    Daimiel Naranjo I; Lo Gullo R; Saccarelli C; Thakur SB; Bitencourt A; Morris EA; Jochelson MS; Sevilimedu V; Martinez DF; Pinker-Domenig K
    Eur Radiol; 2021 Jan; 31(1):356-367. PubMed ID: 32780207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining b2500 diffusion-weighted imaging with BI-RADS improves the specificity of breast MRI.
    Saccenti L; Mellon CM; Scholer M; Jolibois Z; Stemmer A; Weiland E; de Bazelaire C
    Diagn Interv Imaging; 2023 Sep; 104(9):410-418. PubMed ID: 37208291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of combined clinical-radiomics model based on contrast-enhanced MRI in predicting the malignancy of breast non-mass enhancements without an additional diffusion-weighted imaging sequence.
    Li Y; Yang Z; Lv W; Qin Y; Tang C; Yan X; Yin T; Ai T; Xia L
    Quant Imaging Med Surg; 2023 Sep; 13(9):5974-5985. PubMed ID: 37711822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
    Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
    Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidentally detected enhancing lesions found in breast MRI: analysis of apparent diffusion coefficient and T2 signal intensity significantly improves specificity.
    Arponen O; Masarwah A; Sutela A; Taina M; Könönen M; Sironen R; Hakumäki J; Vanninen R; Sudah M
    Eur Radiol; 2016 Dec; 26(12):4361-4370. PubMed ID: 27114285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differential diagnosis of benign and malignant breast lesions using quantitative synthetic magnetic resonance imaging].
    Zhang L; Zhao X; Yin X
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Apr; 42(4):457-462. PubMed ID: 35527481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI.
    Avendano D; Marino MA; Leithner D; Thakur S; Bernard-Davila B; Martinez DF; Helbich TH; Morris EA; Jochelson MS; Baltzer PAT; Clauser P; Kapetas P; Pinker K
    Breast Cancer Res; 2019 Dec; 21(1):136. PubMed ID: 31801635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the "Breast Imaging Reporting and Data System" for multiparametric 3-T imaging of breast lesions.
    Pinker K; Bickel H; Helbich TH; Gruber S; Dubsky P; Pluschnig U; Rudas M; Bago-Horvath Z; Weber M; Trattnig S; Bogner W
    Eur Radiol; 2013 Jul; 23(7):1791-802. PubMed ID: 23504036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.